A French clinical-stage biopharmaceutical Company reached out to Freyr for manuscript preparation and publication in a peer-reviewed journal. The product in scope was a humanized monoclonal antibody fragment that was undergoing a phase IIb trial. Freyr was able to help the client by assisting them with high-quality manuscript preparation and enabled them to gain considerable cost benefits.

To learn more about Freyr's low-cost model for increasing the client's revenue while timely addressing all the review comments, download this proven case.